By Pushkala Aripaka and Nithyashree R B March 27 (Reuters) - AstraZeneca's experimental drug tozorakimab reduced flare-ups of ...
The experimental drug reduced flare-ups for patients with chronic obstructive pulmonary disease, Astra said Friday.
Tozorakimab met the primary goal in two late-stage clinical trials, reducing the rate at which patients’ symptoms worsened, ...
Insmed said Monday that the addition of its drug Arikayce to a standard treatment for patients with a rare bacterial lung ...
A new systematic review and meta-analysis suggests that nerandomilast (Jascayd; Boehringer Ingelheim), an oral therapy for ...
Adding fan-to-face therapy to a supervised exercise training program lowers exertional breathlessness across training ...
Experts warn of ‘attack on Americans’ lungs’ from cuts to health programs, environmental rollbacks and other plans ...
Four types of lung cells — including immune cells — function together on a chip environment that simulates respiration and ...
The Philadelphia hospital treats complex cases and expands access to transplant care for patients who may not qualify ...
A disease called silicosis has affected miners for nearly a century, but now, it's resurfacing in countertop fabrication ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results